{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Anti-CD33_Monoclonal_Antibody_BI_836858",
  "nciThesaurus": {
    "casRegistry": "",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "An engineered, fully human, immunoglobulin (Ig) G1 anti-CD33 monoclonal antibody, with potential antineoplastic activity. Upon administration, anti-CD33 monoclonal antibody BI 836858 induces an antibody-dependent cellular cytotoxicity (ADCC) against CD33-expressing tumor cells, leading to cell death. CD33, a cell surface antigen expressed on normal non-pluripotent hematopoietic stem cells, is overexpressed on myeloid leukemia cells.",
    "fdaUniiCode": "JA7I0QFJ17",
    "identifier": "C116737",
    "preferredName": "Anti-CD33 Monoclonal Antibody BI 836858",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C129822",
      "C20401"
    ],
    "synonyms": [
      "Anti-CD33 Monoclonal Antibody BI 836858",
      "BI 836858",
      "BI-836858"
    ]
  }
}